Table 1.
Clinical Measure | Criteria | Diagnosis | ||||
---|---|---|---|---|---|---|
Central Obesity | Blood Glc | High TG | Low HDL | High BP | ||
AHA/ NHLBI (2009) [4] |
>40” (men) or >35” (women) |
|
|
|
|
≥3 criteria |
IDF (2005) [5,6] |
>32” (women) or
|
≥3 criteria one of which should be central obesity | ||||
ATPIII (2001) [7] |
WC >40” (men) or >35” (women) |
|
|
|
≥3 criteria | |
EGIR (1999) [8] |
>32” (women) |
|
|
|
≥3 criteria one of which should be IR * | |
WHO (1998) [1] |
|
|
|
|
≥3 criteria one of which should be IR ** |
Note that IFG is defined as ≥110 mg/dL in 2001 but this was momdified in 2004 to be ≥100 mg/dL, IGT is defined as 2 h glucose >140 mg/dL. * EGIR IR is defined as plasma insulin levels >75th percentile. ** WHO IR is defined as presence of IR or IFG or IGT. Abbreviations: AHA: American Heart Association, ATPIII: National Cholesterol Education Program Adult Treatment Panel III; dx: diagnosis; EGIR: European group for study of insulin resistance; Glc: glucose; HDL: high density lipoprotein; HTN: hypertension; IR: insulin resistance; IDF: International Diabetes Federation; IGT: impaired glucose tolerance; IFG: impaired fasting glucose; NHLBI: National Heart, Lung, and Blood Institute; TG: triglyceride; txt: treatment; WC: waist circumference; WHO: World Health Organization.